The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CCRN | +14.06% | +77.69% | +12.18% | -41% |
| S&P | +17.53% | +93.66% | +14.13% | +518% |
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the Nurse and Allied Staffing and Physician Staffing segments. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing. The Physician Staffing segment includes certified registered nurse anesthetists, nurse practitioners, and physician assistants. The company was founded by Kevin C. Clark in 1986 and is headquartered in Boca Raton, FL.
The company has elected a new independent director, hoping to grow its business, but investors are selling after a disappointing second quarter.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $274.07M | -19.3% |
| Gross Profit | $51.90M | -21.5% |
| Gross Margin | 18.94% | -0.5% |
| Market Cap | $427.82M | -11.1% |
| Market Cap / Employee | $0.31M | 0.0% |
| Employees | 1.4K | -39.1% |
| Net Income | -$6.66M | 58.5% |
| EBITDA | $5.92M | 171.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $81.19M | 16.7% |
| Accounts Receivable | $201.69M | -16.8% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.46M | -44.9% |
| Short Term Debt | $1.31M | -37.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -1.44% | -2.7% |
| Return On Invested Capital | 12.86% | 3.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $2.25M | -97.2% |
| Operating Free Cash Flow | $4.22M | -94.9% |
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 11.15 | 14.36 | 60.12 | - | |
| Price to Book | 1.03 | 1.39 | 1.15 | 1.01 | -0.13% |
| Price to Sales | 0.31 | 0.44 | 0.38 | 0.36 | 19.17% |
| Price to Tangible Book Value | 1.88 | 2.54 | 2.08 | 1.83 | 5.37% |
| Price to Free Cash Flow TTM | 4.49 | 5.27 | 4.32 | 12.44 | 321.89% |
| Enterprise Value to EBITDA | 46.08 | 76.62 | 65.71 | 58.34 | -219.67% |
| Free Cash Flow Yield | 22.3% | 19.0% | 23.2% | 8.0% | -76.30% |
| Return on Equity | -0.4% | -3.3% | -4.0% | -2.0% | -205.00% |
| Total Debt | $4.41M | $3.87M | $3.31M | $2.77M | -41.57% |
No podcast episodes available.
CCRN earnings call for the period ending September 30, 2021.
CCRN earnings call for the period ending June 30, 2021.
CCRN earnings call for the period ending March 31, 2021.
CCRN earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
